Tokyo experienced a losing streak for the third week in the review period ended March 2. The Nikkei 225 was off 1.3%, closing at the 7,200 level, while the Topix index inched down 0.1%. The first four sessions saw relatively firm movement backed by the weaker yen against major currencies, which encouraged investors to buy back export-oriented issues. However, the market nose-dived on the last trading day amid pessimism regarding the global economic outlook and the financial industry in the USA, with New York markets sinking to historic lows. Active early-week purchasing was reportedly related to establishment of some investment trust funds and moves for "window-dressing" by investment funds trying to make their portfolios look favorable at the end of the financial year. The pharmaceutical index dropped 3.9%, underperforming the market.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze